Literature DB >> 27487522

Secretory function of adipose tissue.

J Kuryszko, P Sławuta, G Sapikowski.   

Abstract

There are two kinds of adipose tissue in mammals: white adipose tissue - WAT and brown adipose tissue - BAT. The main function of WAT is accumulation of triacylglycerols whereas the function of BAT is heat generation. At present, WAT is also considered to be an endocrine gland that produces bioactive adipokines, which take part in glucose and lipid metabolism. Considering its endocrine function, the adipose tissue is not a homogeneous gland but a group of a few glands which act differently. Studies on the secretory function of WAT began in 1994 after discovery of leptin known as the satiation hormone, which regulates body energy homeostasis and maintainence of body mass. Apart from leptin, the following belong to adipokines: adiponectin, resistin, apelin, visfatin and cytokines: TNF and IL 6. Adiponectin is a polypeptide hormone of antidiabetic, anti-inflammatory and anti-atherogenic activity. It plays a key role in carbohydrate and fat metabolism. Resistin exerts a counter effect compared to adiponectin and its physiological role is to maintain fasting glycaemia. Visfatin stimulates insulin secretion and increases insulin sensitivity and glucose uptake by muscle cells and adipocytes. Apelin probably increases the insulin sensitivity of tissues. TNF evokes insulin resistance by blocking insulin receptors and inhibits insulin secretion. Approximately 30% of circulating IL 6 comes from adipose tissue. It causes insulin resistance by decreasing the expression of insulin receptors, decreases adipogenesis and adiponectin and visfatin secretion, and stimulates hepatic gluconeogenesis. In 2004, Bays introduced the notion of adiposopathy, defined as dysfunction of the adipose tissue, whose main feature is insulin and leptin resistance as well as the production of inflammatory cytokines: TNF and IL 6 and monocyte chemoattractant protein. This means that excess of adipose tissue, especially visceral adipose tissue, leads to the development of a chronic subclinical inflammatory condition, which favours the development of insulin resistance and Type 2 diabetes. Obesity is a systemic illness caused by energy transformation homeostasis disorder which results in an increase in the amount of body fat mass. It effects approximately 40% of dogs and 20% of cats. Illnesses which accompany obesity result, to a great extent, from the secretive role of adipose tissue, which is still little known, which should be included when planning treatment of an obese animal.

Entities:  

Mesh:

Year:  2016        PMID: 27487522     DOI: 10.1515/pjvs-2016-0056

Source DB:  PubMed          Journal:  Pol J Vet Sci        ISSN: 1505-1773            Impact factor:   0.821


  18 in total

Review 1.  Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.

Authors:  Yajing Wang; Xin L Ma; Wayne Bond Lau
Journal:  Trends Endocrinol Metab       Date:  2017-05-01       Impact factor: 12.015

2.  Apelin, Omentin-1, and Vaspin in patients with essential hypertension: association of adipokines with trace elements, inflammatory cytokines, and oxidative damage markers.

Authors:  Fatma Behice Serinkan Cinemre; Hakan Cinemre; Nurten Bahtiyar; Behlül Kahyaoğlu; Mustafa Tarık Ağaç; Harika Shundo; Leyla Sevinç; Birsen Aydemir
Journal:  Ir J Med Sci       Date:  2020-06-24       Impact factor: 1.568

3.  Gestational Weight Gain Influences the Adipokine-Oxidative Stress Association during Pregnancy.

Authors:  Juan Mario Solis Paredes; Otilia Perichart Perera; Araceli Montoya Estrada; Enrique Reyes Muñoz; Salvador Espino Y Sosa; Veronica Ortega Castillo; Diana Medina Bastidas; Maricruz Tolentino Dolores; Maribel Sanchez Martinez; Sonia Nava Salazar; Guadalupe Estrada Gutierrez
Journal:  Obes Facts       Date:  2021-09-14       Impact factor: 3.942

4.  Adrenomedullin ameliorates palmitic acid-induced insulin resistance through PI3K/Akt pathway in adipocytes.

Authors:  Hang-Bing Dai; Hong-Yu Wang; Fang-Zheng Wang; Pei Qian; Qing Gao; Hong Zhou; Ye-Bo Zhou
Journal:  Acta Diabetol       Date:  2022-01-03       Impact factor: 4.087

Review 5.  The effect of L-carnitine supplementation on serum leptin concentrations: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ali Nazary-Vannani; Ehsan Ghaedi; Seyed Mohammad Mousavi; Alireza Teymouri; Jamal Rahmani; Hamed Kord Varkaneh
Journal:  Endocrine       Date:  2018-02-16       Impact factor: 3.633

6.  Mesenchymal Stem Cell Differentiation into Adipocytes Is Equally Induced by Insulin and Proinsulin In Vitro.

Authors:  Andreas Pfützner; Dorothee Schipper; Andreas Pansky; Claudia Kleinfeld; Barbara Roitzheim; Edda Tobiasch
Journal:  Int J Stem Cells       Date:  2017-11-30       Impact factor: 2.500

7.  Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes.

Authors:  Haruki Imamura; Daiji Nagayama; Noriko Ishihara; Syo Tanaka; Rena Watanabe; Yasuhiro Watanabe; Yuta Sato; Takashi Yamaguchi; Noriko Ban; Hidetoshi Kawana; Masahiro Ohira; Kei Endo; Atsuhito Saiki; Kohji Shirai; Ichiro Tatsuno
Journal:  Mol Genet Metab Rep       Date:  2017-05-30

8.  Chronic High Dose Zinc Supplementation Induces Visceral Adipose Tissue Hypertrophy without Altering Body Weight in Mice.

Authors:  Xiaohua Huang; Dandan Jiang; Yingguo Zhu; Zhengfeng Fang; Lianqiang Che; Yan Lin; Shengyu Xu; Jian Li; Chao Huang; Yuanfeng Zou; Lixia Li; Bin Feng
Journal:  Nutrients       Date:  2017-10-18       Impact factor: 5.717

9.  Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.

Authors:  Haiming Ma; Guina Zhang; Chunrong Mou; Xiujuan Fu; Yadan Chen
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

10.  Metabolic benefits of inhibition of p38α in white adipose tissue in obesity.

Authors:  Shengjie Zhang; Hongchao Cao; Yan Li; Yanyan Jing; Shengnan Liu; Cheng Ye; Hui Wang; Shuxian Yu; Chengyuan Peng; Lijian Hui; Yu-Cheng Wang; Haibing Zhang; Feifan Guo; Qiwei Zhai; Hui Wang; Ruimin Huang; Ling Zhang; Jingjing Jiang; Wei Liu; Hao Ying
Journal:  PLoS Biol       Date:  2018-05-11       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.